Lord, Abbett & Co
GOSS icon

Lord, Abbett & Co’s Gossamer Bio GOSS Stock Holding History

Lord, Abbett & Co’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-390,146
Closed -$4.41M – 643
2021
Q4 		$4.41M Buy
+390,146
New +$4.63M 0.01% 562

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lord, Abbett & Co's GOSS Position: Q1 2022 in Review

Lord, Abbett & Co sold out of Gossamer Bio (GOSS) in Q1 2022, closing a stake of 390,146 shares — an estimated $4.41M sold.

Lord, Abbett & Co first reported a position in GOSS in Q4 2021 and held it in 1 quarter. The position peaked at $4.41M in Q4 2021. 141 funds tracked by Wall St. Rank hold GOSS as of Q1 2022.

  • Lord, Abbett & Co reported no remaining Gossamer Bio position as of Q1 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 390,146 Gossamer Bio shares in Q1 2022, an estimated $4.41M.
  • Lord, Abbett & Co first reported a position in Gossamer Bio in Q4 2021 and held it in 1 quarter.
  • Lord, Abbett & Co's Gossamer Bio position peaked at $4.41M in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2022.

Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.